WHO ICTRP trial
Isolation, immortalization and characterization of human B lymphocytes for the…
NL-OMON47403 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON47403 |
|---|---|
| Public title | Isolation, immortalization and characterization of human B lymphocytes for the development of diagnostic and therapeutic antibodies against cancer. |
| Scientific title | Isolation, immortalization and characterization of human B lymphocytes for the development of diagnostic and therapeutic antibodies against cancer. - Human antibodies against cancer. |
| Primary sponsor | AIMM Therapeutics BV |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational invasive |
| Countries | The Netherlands |
| Conditions | anti-cancer antibodies / cancer eradication;10024324;10017990;10040900;anti-cancer antibodies / cancer eradication |
| Interventions | ;antibody;B cells;cancer;human |
| Registration date | Feb 21, 2018 |
| Target size | 75 |
| Secondary IDs | NL42718.018.12 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: